iih and glp 1 GLP-1 Drugs Ocular Disease: Between Neuroprotection and Risk glp 1 receptor agonists in

SKU: 90790174901

Pay in 4 interest-free payments of $5.07 Learn more

Live Spec

glp 1 receptor agonists in idiopathic intracranial hypertension Proposed pathophysiological mechanisms underlying IIH and the target GLP 1s may manage idiopathic intracranial hypertension Infographic: Landmark trials in Neuro Ophthalmologyresults of the phase II Idiopathic Intracranial Hypertension Pressure Trial Eye Exenatide (a GLP 1 receptor agonist) rapidly lowered intracranial pressure in active IIH, with a sustained signal at 12 weeks and no meaningful weight change. The authors suggest an ICP lowering Treatment with GLP 1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension The Journal of Headache and Pain Springer Nature Link Impact of GLP 1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity matched multi institutional cohort study in: Journal of Neurosurgery Volume 143 Issue 4 (2025) Journals

Store: www.allread.ai · Domain: www.allread.ai